Streetbeat News

Products Services

MTEM

Molecular Templates, Inc. (NASDAQ:MTEM) has announced the first patient has been dosed in the Phase 1 clinical trial for MT-8421, a novel engineered toxin body targeting CTLA-4, for the treatment of advanced solid tumors. The study will enroll adult patients with tumors where CTLA-4 inhibitors have been proven to provide benefit and in other select tumor types known to frequently have an immune rich tumor microenvironment. Approximately 24-30 patients are anticipated to enroll in Part A dose escalation with a starting dose of 32 mcg/kg.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 9:28 pm

STEM

Stem (NYSE:STEM) and SB Energy have announced a multi-year technology and commercial alliance. The partnership will leverage Stem's AI-driven software and SB Energy's Digital Platform to deploy clean energy at scale. Stem will be SB Energy's preferred partner for the energy management system (EMS) for 10 GWh of SB Energy's energy storage pipeline across North America over the next five years. SB Energy currently owns and operates 2 GW of clean power, increasing to 3 GW by mid-2024.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 9:24 pm

CSTL

Castle Biosciences, Inc. (NASDAQ:CSTL) has announced new data showing the ability of its pipeline test to distinguish between responders and non-responders to an atopic dermatitis therapy. The company's innovative pipeline initiative aims to develop a genomic test to guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis, psoriasis, and related conditions. The test is targeted to launch by the end of 2025. Additional updates regarding the development of this pipeline program are expected in 2024.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 9:24 pm

FIGS

FIGS, Inc. (NYSE:FIGS), a direct-to-consumer healthcare apparel and lifestyle brand, has announced the opening of its first permanent physical retail space, the Community Hub, on November 3, 2023. The hub is located in the Century City Mall, Los Angeles, close to multiple healthcare institutions. The move is in response to the desire of its community to experience FIGS both online and in-person. The company plans to open its next Community Hub in Philadelphia's Rittenhouse Square in the first half of 2024.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 9:23 pm

TERN

Terns Pharmaceuticals has announced the first participant has been dosed in the Phase 1 clinical trial of TERN-601, an oral GLP-1R agonist for the treatment of obesity. The trial will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of TERN-601 in healthy adults with obesity or overweight. The company anticipates 28-day proof of concept data in the second half of 2024. TERN-601 is part of Terns' obesity franchise, which also includes the TERN-600 series of GLP-1R agonists and the TERN-800 series of GIPR modulators.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 9:19 pm

ZM

Carter Osborne's side hustle of helping students get into college has proven to be a lucrative venture, generating over $100K per year. Osborne's business model involves guiding students through the college essay writing process. The business can be run remotely, requiring only a Zoom Video Communications Inc (NASDAQ:ZM) account and a simple website, costing about $50 to set up.

Portfolio Pulse from Adam Eckert

November 02, 2023 | 9:17 pm

KRON

Kronos Bio, Inc. (NASDAQ:KRON) has announced a plan to optimize resource allocation, restructure, and contain costs following positive preliminary clinical data from its Phase 1/2 study of KB-0742. The restructuring plan, which includes a 19% reduction in force, is expected to extend the company's cash runway into 2026. The company will continue to advance the development of lanraplenib and focus on maturing projects and its Genentech collaboration activities.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 9:11 pm

AAPL

SBUX

Starbucks is reportedly collaborating with Apple to experiment and refine technology that will assist its partners across the globe.

Portfolio Pulse from Charles Gross

November 02, 2023 | 9:06 pm

AAPL

Apple Inc has discontinued its $4.99 per month Apple Music Voice Plan, a subscription service that allowed users to access the Apple Music library via Siri on various devices. The most affordable Apple Music offering is now the $5.99 per month Student tier. This move represents a shift in Apple's subscription offerings and pricing structure for Apple Music users.

Portfolio Pulse from Franca Quarneti

November 02, 2023 | 9:05 pm

SBUX

Starbucks plans to focus on brand elevation, strengthening and scaling its digital presence by doubling its rewards members, and accelerating its store expansion to 55,000 globally by 2030.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 9:04 pm